M. Dan

591 total citations
17 papers, 440 citations indexed

About

M. Dan is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, M. Dan has authored 17 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in M. Dan's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotic Resistance in Bacteria (4 papers). M. Dan is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotic Resistance in Bacteria (4 papers). M. Dan collaborates with scholars based in Israel, Romania and United States. M. Dan's co-authors include Bibiana Chazan, Raanan Raz, Walter E. Stamm, Yoram Kennes, Raul Colodner, I. Lavi, S A Berger, Zmira Samra, A Gorea and Alexander Biro and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

M. Dan

15 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Dan Israel 10 245 93 88 80 65 17 440
S. Nys Netherlands 12 281 1.1× 86 0.9× 61 0.7× 172 2.1× 54 0.8× 21 521
D. J. Farrell United States 8 297 1.2× 126 1.4× 53 0.6× 178 2.2× 28 0.4× 14 512
Kelley A. Gordon United States 10 341 1.4× 68 0.7× 45 0.5× 196 2.5× 23 0.4× 11 486
Ronald N. Master United States 9 367 1.5× 80 0.9× 59 0.7× 246 3.1× 31 0.5× 16 597
D. Hoban Canada 11 180 0.7× 28 0.3× 28 0.3× 161 2.0× 24 0.4× 12 400
L. Gualco Italy 12 470 1.9× 115 1.2× 100 1.1× 360 4.5× 67 1.0× 24 794
Andrea Lázár Hungary 12 258 1.1× 60 0.6× 22 0.3× 191 2.4× 26 0.4× 26 564
Behrooz Naghili Iran 12 179 0.7× 76 0.8× 22 0.3× 238 3.0× 22 0.3× 36 563
José L. Bran United States 11 270 1.1× 28 0.3× 25 0.3× 62 0.8× 28 0.4× 12 498
Rahul Mittal United States 9 184 0.8× 38 0.4× 26 0.3× 137 1.7× 13 0.2× 28 479

Countries citing papers authored by M. Dan

Since Specialization
Citations

This map shows the geographic impact of M. Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dan more than expected).

Fields of papers citing papers by M. Dan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dan. The network helps show where M. Dan may publish in the future.

Co-authorship network of co-authors of M. Dan

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dan. A scholar is included among the top collaborators of M. Dan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dan. M. Dan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Dan, M. & Daniela Tălăpan. (2024). Friends or foes? Novel antimicrobials tackling MDR/XDR Gram-negative bacteria: a systematic review. Frontiers in Microbiology. 15. 1385475–1385475. 4 indexed citations
3.
Dan, M., et al.. (2023). Innovative and Needs-led research on β-thalassemia treatment methods. 1. 1 indexed citations
4.
Aursulesei, Viviana & M. Dan. (2012). Peripartum Cardiomyopathy: A Systematic Review. InTech eBooks. 1 indexed citations
5.
Raz, Raanan, Bibiana Chazan, & M. Dan. (2004). Cranberry Juice and Urinary Tract Infection. Clinical Infectious Diseases. 38(10). 1413–1419. 126 indexed citations
6.
Chazan, Bibiana, et al.. (2004). [Cranberry juice and urinary tract infection].. PubMed. 143(12). 891–4, 909. 2 indexed citations
7.
8.
Dan, M., et al.. (1999). Rectal colonization with vancomycin- resistant enterococci among high-risk patients in an Israeli hospital. Journal of Hospital Infection. 43(3). 231–238. 24 indexed citations
9.
Dan, M., et al.. (1992). Peritonitis Caused by Pseudomonas putrefaciens in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis. Clinical Infectious Diseases. 14(1). 359–360. 20 indexed citations
10.
Shalit, Itamar, et al.. (1990). Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus. Antimicrobial Agents and Chemotherapy. 34(3). 494–495. 10 indexed citations
11.
Dan, M. & Zmira Samra. (1989). Clostridium difficile colitis associated with ofloxacin therapy. The American Journal of Medicine. 87(4). 479–479. 15 indexed citations
12.
Dan, M. & Zemira Samra. (1989). Clostridium difficile colitis associated with ofloxacin therapy. The American Journal of Medicine. 87. 479–479. 3 indexed citations
13.
Berger, S A, et al.. (1989). Penetration of Third-Generation Cephalosporins into Human Peritoneal Tissue. Chemotherapy. 35(5). 326–329. 8 indexed citations
14.
Dan, M., et al.. (1988). Cutaneous Manifestations of Infection with Corynebacterium Group JK. Clinical Infectious Diseases. 10(6). 1204–1207. 18 indexed citations
15.
Dan, M., J Golomb, A Gorea, Arie Lindner, & S A Berger. (1987). Penetration of Norfloxacin into Human Prostatic Tissue following Single-Dose Oral Administration. Chemotherapy. 33(4). 240–242. 13 indexed citations
16.
Dan, M., et al.. (1987). Concentration of norfloxacin in human gallbladder tissue and bile after single-dose oral administration. Antimicrobial Agents and Chemotherapy. 31(2). 352–353. 10 indexed citations
17.
Dan, M., S A Berger, Dan Aderka, & Y Levo. (1986). Septicemia caused by the gram-negative bacterium CDC IV c-2 in an immunocompromised human. Journal of Clinical Microbiology. 23(4). 803–803. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Nys Breakdown of academic impact, for papers by D. J. Farrell Breakdown of academic impact, for papers by Kelley A. Gordon Breakdown of academic impact, for papers by Ronald N. Master Breakdown of academic impact, for papers by D. Hoban Breakdown of academic impact, for papers by L. Gualco Breakdown of academic impact, for papers by Andrea Lázár Breakdown of academic impact, for papers by Behrooz Naghili Breakdown of academic impact, for papers by José L. Bran Breakdown of academic impact, for papers by Rahul Mittal
Rankless by CCL
2026